Orbital pseudotumor: distinct diagnostic features and management

Area of Science:

• Ophthalmology
• Orbit Diseases
• Inflammatory Disorders

Background:

• Idiopathic orbital inflammatory syndrome (IOIS), also known as orbital pseudotumor, is a significant intraorbital disease.
• It ranks as the third most common orbital condition, representing 5-10% of all orbital processes.
• IOIS can manifest in various clinical forms, including myositis, dacryoadenitis, and diffuse or localized inflammatory patterns.

Purpose of the Study:

• To provide a comprehensive overview of idiopathic orbital inflammatory syndrome (IOIS).
• To highlight the diagnostic complexities associated with evaluating and managing orbital pseudotumor.
• To emphasize the importance of timely intervention in preventing visual impairment.

Main Methods:

• Literature review focusing on epidemiology, diagnosis, pathophysiology, and treatment of orbital pseudotumor.
• Analysis of diagnostic modalities including ultrasonography (U/S), computed tomography (CT), and magnetic resonance imaging (MRI).
• Summary of treatment strategies, including corticosteroids, biopsy, radiation, and advanced therapies for refractory cases.

Main Results:

• Orbital pseudotumor is a benign condition primarily affecting the orbit, with potential for extraorbital spread.
• Clinical presentations include diplopia, chemosis, proptosis, and optic neuropathy.
• Imaging studies (U/S, CT, MRI) are vital for diagnosis and prognosis, with biopsy confirming the condition.

Conclusions:

• Accurate diagnosis of orbital pseudotumor, differentiating it from other orbital pathologies using imaging, is essential.
• Prompt initiation of appropriate treatment strategies can mitigate visual loss and morbidity.
• A thorough understanding of IOIS clinical features aids in effective patient management.